Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120291) titled 'Effect of perioperative dexmedetomidine on long-term prognosis of patients with renal cell carcinoma after operation' on March 11.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Guangxi Medical University Cancer Hospital
Condition:
Renal Cell Carcinoma
Intervention:
Control group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: Control group:185;Dexmedetomidine group:185;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=304437
Published by HT Digital Content Se...